Nukkleus INC

T3 Defense Inc. has filed an 8-K detailing a 1-for-125 reverse stock split, effective July 20, 2026, aimed at regaining compliance with Nasdaq listing rules.

T3 Defense Inc. announced the termination of a non-binding letter of intent for a potential business combination with SC II Acquisition Corp., a SPAC.

T3 Defense Inc. is implementing a 1-for-50 reverse stock split to regain compliance with Nasdaq listing rules.

T3 Defense Inc. has acquired a 60% stake in Project 35, an Israeli defense technology firm, through a combination of stock issuance and a promissory note, bolstering its counter-UAV capabilities.

T3 Defense Inc. announced the approval of several critical proposals at its special stockholder meeting on June 24, 2026, including share issuances and potential reverse stock split authorization.

T3 Defense Inc. has postponed its special stockholder meeting originally scheduled for June 18, 2026, to June 24, 2026, with no changes to the record date or proposals.

T3 Defense Inc. reported Q1 2026 financial results, announced a strategic share exchange with VisionWave Holdings, and addressed a Nasdaq minimum bid price deficiency.

Nukkleus Inc. reports a strategic shift to defense and AI, divesting financial services while securing significant capital and pursuing multiple acquisitions, despite ongoing operational losses and internal control weaknesses.

Nukkleus Inc. reported a significant Q2 2025 net income driven by non-cash gains, as it strategically shifts from financial technology to the defense sector while facing substantial liquidity challenges.

Nukkleus Inc. filed an amendment to its quarterly report for the period ended March 31, 2025, to explicitly state that its disclosure controls and procedures were not effective due to material weaknesses in internal control over financial reporting.

Nukkleus Inc. reported a substantial net income for Q1 2025 driven by non-cash fair value adjustments of liabilities, as it continues its strategic shift from financial technology to the defense sector through the acquisition of Star 26 Capital Inc.

Nukkleus Inc. reports a significant net loss for the third quarter of 2024, impacted by the termination of a key service agreement and increased operating expenses.

T3 Defense Inc. (formerly Nukkleus Inc.) has finalized its transformation into an aerospace and defense company, announcing several key acquisitions and a new strategic direction.

Nukkleus Inc. filed an amendment to its annual report, revealing that its internal controls over financial reporting were not effective as of December 31, 2024, due to identified material weaknesses.

Nukkleus Inc. is transitioning its business focus to the defense sector through the acquisition of Star 26 Capital, while also restructuring its finances and discontinuing certain operations.

Nukkleus Inc. files an amendment to its annual report to include information on its policy for recovering erroneously awarded compensation, while also detailing its business strategy, recent developments, and financial performance.

Nukkleus Inc. announces a strategic shift towards the defense sector by acquiring a controlling interest in Star 26 Capital, a defense acquisition company, while navigating financial challenges and restructuring its operations.

Nukkleus Inc.'s 10-K filing details service agreements with FML Malta and FXDirectDealer, alongside its financial performance and strategic shift towards blockchain-enabled technology solutions.

Menachem Shalom, Director and CEO of T3 Defense Inc., reported significant transactions involving common stock and warrants on April 27, 2026.

Nukkleus Inc. CEO Menachem Shalom exercised warrants to acquire 200,000 shares of common stock at $1.50 per share, increasing his direct ownership.

Nukkleus Inc. CEO Menachem Shalom increased his beneficial ownership of common stock and warrants following the acquisition of Star 26 Capital, Inc.

Anastasiia Kotaieva, a former director and 10% shareholder of Nukkleus Inc., has fully divested her remaining common stock holdings.

Anastasiia Kotaieva, a former director and 10% owner of Nukkleus Inc., reported selling 211,208 shares of common stock across four transactions in late December 2025.

Anastasiia Kotaieva, a former director and 10% owner of Nukkleus Inc., reported the sale of 108,744 shares of common stock in mid-December 2025 under a Rule 10b5-1 plan.

T3 Defense Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for August 5, 2026, to be held virtually, with key proposals including director elections, auditor ratification, and the adoption of a new equity incentive plan.

T3 Defense Inc. is convening a special meeting of stockholders on June 18, 2026, to vote on crucial proposals including the issuance of shares related to warrants and preferred stock, and a potential reverse stock split to regain Nasdaq compliance.

Nukkleus Inc. announces the acquisition of 100% of Star, a related party, for $73.4 million, pivoting its business focus to the defense sector, subject to shareholder approval.

Nukkleus Inc. calls a Special Meeting to approve the acquisition of Star Capital 26, Inc., along with significant equity issuances for warrants and an equity line of credit, all requiring Nasdaq compliance.

Nukkleus Inc. announced its 2025 Annual Meeting of Stockholders to vote on director elections, auditor ratification, and a new equity incentive plan, alongside details of a significant acquisition of Star, a defense and technology company.

Nukkleus Inc. is set to hold its 2024 Annual Meeting of Stockholders virtually on October 11, 2024, to vote on key proposals including director elections, auditor ratification, a reverse stock split, an equity incentive plan, and an increase in authorized shares.

T3 Defense Inc. has filed an amendment to its S-1 registration statement to facilitate the resale of up to 30 million shares of common stock by selling stockholders.

T3 Defense Inc., formerly a financial technology firm, is transforming into an aerospace and defense acquirer and operator, facing significant operational and financial challenges while registering shares for resale by existing investors.

T3 Defense Inc. (formerly Nukkleus Inc.) has completed a strategic transformation from financial technology to aerospace and defense, marked by several acquisitions and a significant capital raise.

Nukkleus Inc. is undergoing a radical business transformation from financial technology to aerospace and defense, marked by strategic acquisitions and significant capital raises, yet faces substantial financial and operational risks.

Nukkleus Inc. is undergoing a complete business transformation from fintech to aerospace and defense, securing a $250 million equity line of credit and pursuing multiple acquisitions despite significant financial challenges and a going concern warning.

Nukkleus Inc. is strategically shifting its business focus from financial technology to the defense sector through the acquisition of Star 26 Capital Inc., while grappling with significant historical losses, a working capital deficit, and ongoing going concern uncertainties.

X S.E. Security and Defense Ltd. and Elad Shohat have jointly filed a Schedule 13D, disclosing beneficial ownership of 168,479 shares, representing 16.67% of T3 Defense Inc.'s common stock.

Menachem Shalom has increased his beneficial ownership in T3 Defense Inc. to 25.4% through warrant exercises and note conversions, as detailed in an amended Schedule 13D filing.

An amendment to a Schedule 13D filing reveals that Menachem Shalom, along with affiliated entities, now beneficially owns 20.4% of BiomX Inc. common stock following a business acquisition.

BiomX Inc. has acquired Zorro Net Ltd., a visual AI and computer vision technology firm, from Water IO Ltd. for 1.3 million shares of BiomX common stock and a $1.25 million promissory note.

Nukkleus Inc.'s CEO, Menachem Shalom, has increased his beneficial ownership to 26.0% and entered into a call option agreement to potentially repurchase shares from Esousa Group Holdings LLC.

VisionWave Holdings, Inc. has reported beneficial ownership of 6,000,000 shares, representing 9.96% of T3 Defense Inc.'s common stock, as of May 17, 2026.

Esousa Group Holdings LLC and Michael Wachs have disclosed a 9.9% beneficial ownership stake in Nukkleus Inc., primarily through convertible preferred stock and warrants.

Esousa Group Holdings LLC and Michael Wachs have disclosed a continued beneficial ownership of 9.99% in Nukkleus Inc., comprising common stock, pre-funded warrants, and warrants.

Esousa Group Holdings LLC and Michael Wachs have filed an amended Schedule 13G, revealing a beneficial ownership of 9.99% in Nukkleus Inc.'s common stock as of December 31, 2024.